Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death

Biotechnology and Applied Biochemistry

Volumn 40, Issue 2, 2004, Pages 157-165

  Roeder, Geraldine E ^a   Parish, Joanna L ^a   Stern, Peter L ^b   Gaston, Kevin ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Cancer; Herpes simplex virus type 1 (HSV 1); Human papillomavirus (HPV); Human papillomavirus E2 protein; Therapy

Indexed keywords

BACTERIA; CARCINOGENS; CELLS; DISEASE CONTROL; DNA; GENES; PATIENT TREATMENT; PROTEINS;

APOPTOSIS; BACTERIAL CELLS; CERVICAL CANCER CELL; DNA-BINDING PROTEINS;

VIRUSES;

DNA BINDING PROTEIN; HERPES SIMPLEX VIRUS VP22 PROTEIN; HUMAN PAPILLOMAVIRUS E2 PROTEIN; HYBRID PROTEIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS T ANTIGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIAL CELL; CANCER CELL CULTURE; CELL GROWTH; CELL STRAIN COS7; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PROTEIN PROTEIN INTERACTION; SIMIAN VIRUS 40; UTERINE CERVIX CANCER; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; WART VIRUS;

ANIMALS; APOPTOSIS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; GENE TARGETING; GENE THERAPY; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; NEOPLASMS; ONCOGENE PROTEINS, VIRAL; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TREATMENT OUTCOME; VIRAL STRUCTURAL PROTEINS;

ANIMALIA; BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 1; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; MAMMALIA; PAPILLOMAVIRUS; SIMIAE; SIMIAN VIRUS 40; SIMPLEXVIRUS;

EID: 5444245439     PISSN: 08854513     EISSN: None     Source Type: Journal    
DOI: 10.1042/BA20030172     Document Type: Article

References (31)

1. Ferlay, J., Bray, F., Pisani, P. and Parkin, D. M. (2001) IARC Cancer Base No. 5, IARC Press, Lyon, France
2. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummen J. A., Shah, K. V., Snijders, P. J., Peto, J., Meijer, C. J. and Munoz, N. (1999) J. Pathol. 189, 12-19
3. Dell, G. and Gaston, K. (2001) Cell. Mol. Life Sci. 58, 1923-1942
4. Kalantari, M., Blennow, E., Hagmar; B. and Johansson, B. (2001) Diagn. Mol. Pathol. 10, 46-54
5. Dürst, M., Kleinheinz, A., Hotz, M. and Gissman, L. (1985) J. Gen. Virol. 66, 1515-1522
6. Hegde, R. S. (2002) Annu. Rev. Biophys. Biomol. Struct. 31, 343-360
7. Frattini, M. G. and Laimins, L. A. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 12398-12402
8. Hwang, E. S., Riese, D. J., II, Settleman, J., Nilson, L. A., Honig, J., Flynn, S. and DiMaio, D. (1993) J. Virol. 67, 3720-3729
9. Desaintes, C., Demeret, C., Goyat, S., Yaniv, M. and Thierry, F. (1997) EMBO J. 16, 504-514
10. Sanchez-Perez, A. M., Soriano, S., Clarke, A. R. and Gaston, K. (1997) J. Gen. Virol. 78, 3009-3018
11. Webster, K. J., Parish, J., Pandya, M., Stern, P. L., Clarke, A. R. and Gaston, K. (2000) J. Biol. Chem. 275, 87-94
12. Francis, D. A., Schmid, S. I. and Howley; P. M. (2000) J. Virol. 74, 2679-2686
13. Nishimura, A., Ono, T., Ishimoto, A., Dowhanick, J. J., Frizzell, M. A., Howley, P. M. and Sakai, H. (2000) J. Virol. 74, 3752-3760
14. Massimi, P., Pim, D., Bertoli, C., Bouvard, V. and Banks, L. (1999) Oncogene 18, 7748-7754
15. Lepik, D., Ilves, I., Kristjuhan, A., Maimets, T. and Ustav, M. (1998) J. Virol. 72, 6822-6831
16. Valdez Graham, V., Sutler, G., Jose, M. V., Garcia-Carranca, A., Erfle, V., Moreno Mendoza, N., Merchant, H. and Rosales, R. (2000) Cancer 88, 1650-1662
17. Elliott, G. and O'Hare, P. (1997) Cell (Cambridge, Mass.) 88, 223-233
18. Brewis, N., Phelan, A., Webb, J., Drew, J., Elliott, G. and O'Hare, P. (2000) J. Virol. 74, 1051-1056
19. Phelan, A., Elliott, G. and O'Hare, P. (1998) Nat. Biotechnol. 16, 440-443
20. Wills, K. N., Atencio, I. A., Avanzini, J. B., Neuteboom, S., Phelan, A., Philopena, J., Sutjipto, S., Vaillancourt, M. T., Wen, S. F., Ralston, R. O. et al. (2001) J. Virol. 75, 8733-8741
21. Zender, L., Kühnel, F., Köck, R., Manns, M. and Kubicka, S. (2002) Cancer Gene Ther. 9, 489-496
22. Earnshaw, W. C. (1995) Curr. Opin. Cell Biol. 7, 337-343
23. Demeret, C., Garcia-Carranca, A. and Thierry, F. (2003) Oncogene 22, 168-175
24. Leifert, J. A. and Whitton, J. L. (2003) Mol. Ther. 8, 13-20
25. Elliott, G. and O'Hare, P. (1999) J. Virol. 73, 4110-4119
26. Bechtold, V., Beard, P. and Raj, K. (2003) J. Virol. 77, 2021-2028
27. Brady, C. S., Bartholomew, J. S., Burt, D. J., Duggan-Keen, M. F., Glenville, S., Telford, N., Little, A. M., Davidson, J. A., Jimenez, P., Ruiz-Cabello, F. et al. (2000) Tissue Antigens 55, 401-411
28. Basta, A., Adamek, K. and Pitynski, K. (1999) Eur. J. Gynaecol. Oncol. 20, 111-114
29. Gross, G. (1997) Intervirology 40, 368-377
30. Cheng, W.-F., Hung, C.-F., Chai, C.-Y., Hsu, K.-F., He, L., Ling, M. and Wu, T.-C. (2001) J. Virol. 75, 2368-2376
31. Davidson, E. J., Brown, M. D., Burt, D. J., Parish, J. L., Gaston, K., Kitchener, H. C., Stacey, S. N. and Stern, P. L. (2001) Int. J. Cancer 94, 807-812